2m 2m 2m 2m 2m 2m 2m
OMNIAB (OABI)
NASDAQ
$4.23-$0.11 (-2.42%)
Price as of Aug 21, 2026 7:39 PM EDT- $629.5MMarket Cap
- 134.05%1-Year Change
- BiotechnologyIndustry
OMNIAB (OABI)
$4.23-$0.11 (-2.42%)
OABI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.33 | ||
Change | +$0.03 (+0.70%) | ||
Open | $4.31 | ||
High | $4.54 | ||
Low | $4.14 | ||
Previous Close | $4.30 | ||
Volume | 1,852,682 | ||
30-Day Average Volume | 1,777,341 | ||
1-Week Change | 28.11% | ||
1-Month Change | 107.18% | ||
1-Year Change | 134.05% | ||
3-Year Change | -25.34% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 145.4M | ||
Total Assets | $290.3M | ||
Market Cap | $629.5M | ||
Enterprise Value | $605.2M | ||
Period: QTR TTM FY | |||
Revenue | $9.5M | ||
Net Income | -$5.9M | ||
Free Cash Flow | $2.6M | ||
EBIT | -$6.2M | ||
EBITDA | -$3.2M | ||
Net Working Capital | $52.3M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | -192 | ||
Enterprise Value/Revenue | 64 | ||
P/B | 2 | ||
P/E | -87 | ||
PEG | -5 | ||
Price/Free Cash Flow | 245 | ||
Price/Operating Cash Flow | 235 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue